TMCnet News
MDxHealth (R): Annual General Shareholders' MeetingNEWS RELEASE REGULATED INFORMATION Annual General Shareholders’ Meeting IRVINE, CA, and HERSTAL, BELGIUM – [18:00 CEST], May 29, 2019 – MDxHealth SA (Euronext: MDXH) held today its Annual General Shareholders' Meeting in Brussels. The shareholders approved all agenda items of the Annual General Shareholders' Meeting, including the financial statements for the financial year ended December 31, 2018. In addition, the company held an Extraordinary General Shareholders' Meeting. As the required quorum was not met for this meeting, a new Extraordinary General Shareholders' Meeting will be held on June 21, 2019. About MDxHealth MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of therapeutic response. The Company's European headquarters are in Herstal, Belgium, with laboratory opeations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx, SelectMDx, AssureMDx, PredictMDx and UrNCollect are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.Disclaimer
Attachment |